Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Third Rock Wise To The Opportunity In CNS; Stakes SAGE Therapeutics With $35 Million

Oct 18 2011

• By The Pink Sheet Daily

Related Content

Blueprint Medicines Takes $40MM From Third Rock To Build Oncology Platform

Apr 12 2011

Scrappy Addex Has A Plan For Reviving Faith In Its Allosteric Modulators

May 13 2010

Lotus Tissue Repair Scores $26 Million in Series A Round

Jun 29 2011

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window